Therefore, Kcnq1ot1/miR-214-3p/caspase-1/TGF-β1 signal pathway presents a new mechanism of DCM progression and could potentially be a novel therapeutic target. This evidence concerns the gene CASP1 and familial dilated cardiomyopathy.